As of Noon on October 14, 2022, the Kansas Statewide Immunization Protocol is no longer effective and should not be used to immunize Kansas patients. If you have previously signed and provided vaccines under the protocol, please retain a copy of the dually signed protocol for at least five years at the location where any vaccine was provided under the authority of the protocol. Show
Pharmacists planning to continue providing immunizations to patients may use the following methods: 1. Pharmacists may enter into an immunization protocol with a Kansas-licensed physician to administer vaccines or authorize pharmacist interns to administer vaccines. A sample immunization protocol is provided below. The 2021 updates to the Kansas Pharmacy Practice Act require any immunization protocol be signed by the authorizing physician and the administering pharmacist. Copies of the signed protocol should be retained for five years at the location(s) where
immunizations are provided, but do not need to be sent to the Board office. 2. Under the Federal PREP Act, pharmacists may independently order and administer FDA-approved vaccines to children ages 3-18 years, influenza vaccines to persons 19 years and older pursuant to the CDC/ACIP standard immunization schedule, and order and administer FDA-authorized or FDA-licensed COVID-19 vaccines to persons 3 years or older. Furthermore, pharmacist interns and pharmacy technicians may administer these immunizations under the direct supervision of the pharmacist who has ordered the immunization. Participating pharmacists, interns, and technicians must:
3. To alleviate any
potential for patient harm, patients needing a second vaccine to complete a series initiated under the previous statewide protocol should be administered that vaccine in accordance with that protocol. For example, this means that those patients who need the second in the Zoster series should be able to receive the vaccine. Erick Axcell, PharmD, Non-Voting Chair Benefits to PracticeWhile CPAs are not a prerequisite for collaborative care delivery, they can serve to improve the efficiency and effectiveness of collaborative care delivery. When used to their full potential, CPAs have the ability to increase access to care, expand available services to patients, increase the efficiency and coordination of care, and leverage pharmacists’ medication expertise to complement the skills and knowledge of the other health care team members. For example, CPAs can decrease the number of phone calls required to authorize refills or modify prescriptions, thus allowing each member of the health care team to complement the skills and knowledge of the other member(s), more effectively facilitate patient care, and improve patient outcomes. Applications of CPAsA variety of patient care functions---such as initiating, modifying, or discontinuing medication therapy---can be delegated to a pharmacist using a CPA. These functions can facilitate the delivery of services such as:
Toolkit: Advancing Team-Based Care through CPAsPharmacists looking to develop a collaborative practice agreement may need assistance figuring out where to start. To help with that process, a toolkit entitled "Advancing Team-Based Care through Collaborative Practice Agreements" has been developed. The toolkit is a resource for pharmacists to use in developing and executing collaborative practice agreements in the spirit of advancing team-based care. It provides a customizable template that can be used as a starting point to developing a collaborative practice agreement. This toolkit was developed by ChangeLab Solutions, the Centers for Disease Control and Prevention (CDC), the National Alliance of State Pharmacy Associations (NASPA), and the American Pharmacists Association (APhA) through a cooperative agreement with ChangeLab Solutions. Download the Toolkit Where to Learn MoreFor more information on CPA's and related pharmacist-provided services, check out the following resources. From NASPA:
From APhA:
From CDC:
Support for Pharmacists Services:
KPhA appreciates the generous support provided byHow do you write a collaborative practice agreement?According to the CDC, a collaborative practice agreement should include these parts:. Explanation of the purpose of the agreement.. A list of the parties to the agreement.. The patients who are included in the agreement (either a specific list of patients or a group of patients). Care functions authorized by the agreement.. What is a collaborative agreement in pharmacy?Pharmacist Collaborative
Practice Agreement (CPA) A formal agreement in which a licensed provider makes a diagnosis, supervises patient care, and refers patients to a pharmacist under a protocol that allows the pharmacist to perform specific patient care functions.
How do pharmacists work with other healthcare professionals?“They often make clinical rounds with other team members. They participate in developing medication therapy plans, dispensing (including compounding) [medications], monitoring patients' responses to treatments, and providing patient education.”
Why is it important for pharmacists to collaborate with other professions?To ensure excellent quality of medical care, interprofessional cooperation between physicians and pharmacists and/or other medical professionals is necessary. Their complementary knowledge and experience can lead to improved health outcomes and can also reduce treatment costs.
|